Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Celularity (CELU) Equity Ratio (2020 - 2025)

Historic Equity Ratio for Celularity (CELU) over the last 6 years, with Q3 2025 value amounting to 0.18.

  • Celularity's Equity Ratio fell 23114.72% to 0.18 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.18, marking a year-over-year decrease of 23114.72%. This contributed to the annual value of 0.07 for FY2024, which is 7660.3% down from last year.
  • Celularity's Equity Ratio amounted to 0.18 in Q3 2025, which was down 23114.72% from 0.21 recorded in Q2 2025.
  • In the past 5 years, Celularity's Equity Ratio registered a high of 0.5 during Q4 2022, and its lowest value of 0.37 during Q2 2021.
  • Moreover, its 5-year median value for Equity Ratio was 0.21 (2022), whereas its average is 0.16.
  • As far as peak fluctuations go, Celularity's Equity Ratio skyrocketed by 115501.0% in 2021, and later plummeted by 23114.72% in 2025.
  • Celularity's Equity Ratio (Quarter) stood at 0.24 in 2021, then surged by 106.58% to 0.5 in 2022, then crashed by 42.6% to 0.28 in 2023, then tumbled by 76.6% to 0.07 in 2024, then plummeted by 364.09% to 0.18 in 2025.
  • Its Equity Ratio was 0.18 in Q3 2025, compared to 0.21 in Q2 2025 and 0.04 in Q1 2025.